Douglas A Melton

USPTO Granted Patents = 40 (Patent Applications = 36)

EPO Patents = 5 (Patent Applications = 20)

Average Co-Inventor Count = 3.3

ph-index = 12

Forward Citations = 478(Granted Patents)

Location History:

Lexington, MA (US) (1997 - 2024)
Cambridge, MA (US) (2023 - 2024)

Company Filing History:

Genetics Institute, Inc.

patents

2 out of 1,373

The Brigham and Women's Hospital, Inc.

patents

4. 1 out of 1

Genetics, Institute Institute, Llc.

patent

5. 1 out of 2,893

The General Hospital Corporation

Children's Medical Center Corporation

patents

8. 2 out of 832,843

Other

patents

where one patent can have more than one assignee

Years Active: 1997-2024

Loading Chart...

Areas of Expertise:

Stem Cell-Derived Beta Cells

Diabetes Treatment

Cardiomyocytes Production

Endocrine Cell Generation

PDX1+ Pancreatic Cells

Definitive Endoderm

Neuronal Cell Induction

Glycogen Synthase Kinase-3 Inhibitors

TGF-beta Signal Transduction

Tendon-Inducing Methods

Serum-Free Differentiation Protocols

Weight Gain Prevention

40 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12123023 - Methods for generating stem cell-derived β cells and methods of use thereof (2024-10-22),

2. 12097239 - Methods and compositions for treating diabetes, and methods for enriching MRNA coding for secreted proteins (2024-09-24),

3. 12054745 - SC-beta cells and compositions and methods for generating the same (2024-08-06),

4. 12049646 - SC-beta cells and compositions and methods for generating the same (2024-07-30),

5. 11890321 - Method of treating or inhibiting glucose intolerance (2024-02-06),

6. 11850266 - Cardiomyocytes and compositions and methods for producing the same (2023-12-26),

7. 11827905 - SC-beta cells and compositions and methods for generating the same (2023-11-28),

8. 11162078 - SC-beta cells and compositions and methods for generating the same (2021-11-02),

9. 11155787 - Methods for generating stem cell-derived beta cells and methods of use thereof (2021-10-26),

10. 11136554 - Methods of reprogramming cells (2021-10-05),

11. 11104883 - SC-beta cells and compositions and methods for generating the same (2021-08-31),

12. 11085027 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

13. 11085026 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

14. 11085025 - Serum-free in vitro directed differentiation protocol for generating stem cell-derived beta cells and uses thereof (2021-08-10),

15. 11078463 - SC-beta cells and compositions and methods for generating the same (2021-08-03),

Title: Douglas A. Melton - Pioneering Inventor from Lexington, MA

Introduction: Douglas A. Melton is a renowned inventor based in Lexington, MA, known for his groundbreaking contributions to the field of science and technology.

Latest Patents: Douglas A. Melton holds several patents in the areas of biotechnology and medical research, focusing on innovative solutions for various health challenges.

Career Highlights: With a distinguished career spanning decades, Douglas A. Melton has made significant strides in stem cell research, diabetes treatment, and regenerative medicine, earning him global recognition.

Collaborations: Throughout his career, Douglas A. Melton has collaborated with leading scientists, research institutions, and pharmaceutical companies to further advance the frontiers of scientific discovery and innovation.

Conclusion: Douglas A. Melton's relentless pursuit of scientific excellence and his commitment to improving human health through innovative inventions continue to inspire the next generation of inventors and researchers worldwide.

This text is generated by artificial intelligence and may not be accurate.